Also, we observed that patients with CASPR2 antibody disease often fall outside of diagnostic criteria25 for autoimmune encephalitis, as many only present after 3 months (as previously reported4), yet late immunotherapy remains effective in improving QoL and mRS. Here, CNTNAP2 is linked to autoimmune encephalitis.